Phase 1 Safety and Pharmacokinetic Study of AI-700 in Patients With Diminished DLCO and COPD and/or CHF

NCT00156780 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Congestive Heart Failure
Chronic Obstructive Pulmonary Disease

Interventions

DRUG: AI-700

Sponsor

Acusphere